Over 50 Percent Antibiotics Prescribed In India Have Potential To Cause High AMR

New Delhi: Over 50 percent of antibiotics prescribed in India are those with a potential to cause high antimicrobial resistance, according to a government report based on India’s first large-scale multi-centric study on the use of the medicines. The report calls this a “concerning trend”.

The First Multicentric Point Prevalence Survey of Antibiotic Use at 20 NAC-NET Sites India 2021-22 was conducted by the National Centre for Disease Control (NCDC) under the Union health ministry.

The report was released Tuesday.

The National Antimicrobial Consumption Network (NAC-NET) consists of 35 tertiary-care institutes across India, and has been monitoring antibiotic consumption at these facilities for the past five years.

According to the report, the survey findings indicate a “remarkably high prevalence” of antibiotic usage (71.9 percent), with 4.6 percent of the patients getting four or more antibiotics.

Out of the 20 sites where the assessment was carried out, four had more than 95 percent prevalence of antibiotic use, the report says, before offering a breakdown of the types prescribed (‘watch’ or ‘access’).

According to the AWaRe classification of antibiotics developed by the World Health Organization (WHO) in 2017, ‘watch’ antibiotics generally have a higher potential for antimicrobial resistance, and are more commonly used in sicker patients in medical facilities.

These medicines, according to the world health body, should be prescribed carefully to avoid misuse.

Access antibiotics are those with a narrow spectrum of activity, generally with fewer side-effects, and a lower potential for antimicrobial resistance and lower cost.

These are recommended for the empiric treatment of most common infections.

The classification also includes a third group — ‘reserve’ antibiotics — that are last-resort medicines and should only be used to treat severe infections caused by multidrug-resistant pathogens.

The government survey found that, at 57 percent, ‘watch’ group antibiotics were on average prescribed more frequently at the 20 sites, than those under ‘access’ (38 percent). The trend was the other way round at two sites.

In 2019, the WHO included antimicrobial resistance as one of the top 10 threats to public health.

The report says that the discovery of antibiotics has been a groundbreaking advancement that revolutionised the approach to infectious diseases, but these “once-miraculous drugs” have become less effective due to various factors.

“One of these factors is the indiscriminate, excessive, and inappropriate use of antibiotics,” it says.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert